BiomX Inc. (PHGE) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 4 Buy, 1 Hold.
The consensus price target is $2.00, representing a downside of 9.5% from the current price $2.21.
Analysts estimate Earnings Per Share (EPS) of $-46.84 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.41 vs est $-46.84 (beat +103%). 2025: actual $-22.19 vs est $-20.35 (missed -9%). Analyst accuracy: 0%.
PHGE Stock — 12-Month Price Forecast
$2.00
▼ -9.50% Downside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for BiomX Inc., the price target is $2.00.
The average price target represents a -9.50% change from the last price of $2.21.
PHGE Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to BiomX Inc. in the past 3 months
EPS Estimates — PHGE
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $1.41
vs Est –$46.84
▲ 3,421.6% off
2025
Actual –$22.19
vs Est –$20.35
▼ 8.3% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect losses to continue near-term.
Revenue Estimates — PHGE
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
